Bright Minds Biosciences (DRUG) Change in Accured Expenses (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Change in Accured Expenses of $1.7 million for Q1 2026, up 451.01% on a QoQ basis from -$471518.7 in Q4 2025, and up 1285.89% year-over-year from $119422.9 in Q1 2025.
Bright Minds Biosciences (DRUG) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | Bright Minds Biosciences | 683.37 Mn | 683.37 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -471,518.65 |
| Dec 31, 2025 | -471,518.65 |
| Jun 30, 2025 | -24,114.58 |
| Jun 30, 2025 | -24,114.58 |
| Mar 31, 2025 | 119,422.91 |
| Mar 31, 2025 | 119,422.91 |
| Dec 31, 2024 | -43,267.35 |
| Dec 31, 2024 | -43,267.35 |
| Jun 30, 2024 | -472,640.69 |
| Jun 30, 2024 | -472,640.69 |
| Mar 31, 2024 | 8,503.13 |
| Mar 31, 2024 | 8,503.13 |
| Dec 31, 2023 | 435,058.05 |
| Dec 31, 2023 | 435,058.05 |
| Jun 30, 2023 | 918,296.26 |
| Jun 30, 2023 | 918,296.26 |
| Mar 31, 2023 | 350,628.65 |
| Mar 31, 2023 | 350,628.65 |